154 results
Page 3 of 8
POS AM
xrysxt7zt7
20 Sep 22
Prospectus update (post-effective amendment)
9:13am
POS AM
v8gcfe o6mniy3bt
20 Sep 22
Prospectus update (post-effective amendment)
9:10am
8-K
EX-4.2
8f79nm6imdb 9gw
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.1
nqwom6
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
rupw5rf
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.2
recl356flgr7
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.3
tbs o3yhozz
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
7l5vc8u plmxtx
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
424B3
8k41f833tf0s9 w285v
6 Jul 22
Prospectus supplement
2:43pm
8-K
EX-10.2
hk8i lrjjoi9wy5psg0
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.3
kw2 a8thnfu
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.1
v3sk2e9d6l2qv8rx5wpf
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.2
w8a68
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
1g8fyxbtdc
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.3
k9nqsomn
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
vjxqdyse
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B5
z8yxvpud75a95aem4ohl
1 Jun 22
Prospectus supplement for primary offering
5:20pm